« Back
Home /
Ac2-26 (TFA)

Ac2-26 (TFA)

Manufacturer	MedChem Express
Category	Peptides & Proteins Peptides
Type	Peptides
Specific against	other
Amount	5 mg
Item no.	HY-P1098A-5mg
eClass 6.1	34160400
eClass 9.0	32160409
Available
Product Description	Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue[1].
StorageTemperature	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Shipping	Blue Ice
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	3203.45
Clinical_Information	No Development Reported
Manufacturers Research_Area	Inflammation/Immunology
Solubility	DMSO : 50 mg/mL (ultrasonic)\|H2O : 1.93 mg/mL (ultrasonic; adjust pH to 10 with H2O)
Manufacturers Target	NF-κB
Pathway	NF-κB
Manufacturers Product type	Peptides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-P1098A-5mg-safety-datasheet.pdf